Laser Iridoplasty: Can It Save Your Vision?
"Exploring the enduring effects of laser iridoplasty as a vision-saving treatment for angle closure"
For individuals with primary angle closure (PAC), a condition where the drainage angle in the eye narrows or closes, leading to increased intraocular pressure, laser iridoplasty (LI) emerges as a ray of hope. This procedure becomes particularly relevant when traditional iridotomy—creating a hole in the iris to improve fluid flow—fails to fully open the angle. LI offers a different approach, reshaping the iris to widen the angle and reduce pressure.
The effectiveness of laser iridoplasty lies in its dual action: thinning the iris tissue and causing both circumferential and radial contraction. Imagine the iris as a curtain; LI essentially pulls this curtain back, away from the trabecular meshwork, the eye’s drainage system. By doing so, it aims to restore the natural outflow of fluid, preventing the buildup of pressure that can damage the optic nerve.
While the immediate benefits of LI have been well-documented through spectral domain anterior segment optical coherence tomography (ASOCT), the long-term durability of its effects has been a subject of ongoing discussion. Now, let’s delve into the lasting impact of laser iridoplasty and what it means for those seeking to preserve their vision.
A Procedure Still Building Its Evidence Base
When reviewed for its role in angle-closure, laser peripheral iridoplasty was the subject of only one randomized controlled trial, which included 158 participants. The procedure is described as a precise, outpatient technique designed to improve the eye's drainage and reduce intraocular pressure safely. It can be used for an acute angle-closure crisis as well as in non-acute situations, and it has been studied as an initial treatment for an acute attack of primary angle closure. For chronic angle closure that persists after laser peripheral iridotomy, however, previous reviews have found insufficient data to determine its clinical effectiveness compared with other interventions.
Low-Energy Burns That Pull Open the Angle
The standard approach uses low-energy contraction burns on the iris to mechanically pull open the drainage angle, thereby reducing intraocular pressure. In acute angle closure, researchers have reported that argon-laser peripheral iridoplasty limited to the inferior 180 degrees of the iris was also effective in lowering intraocular pressure. The procedure is typically applied when angle closure persists after laser peripheral iridotomy, particularly in chronic cases. A key limitation, however, is that prior reviews have found insufficient data to determine the clinical effectiveness of laser peripheral iridoplasty compared with other interventions.
From Argon Burns to the Molding of the Iris
Iridoplasty, literally the molding of the iris, was developed using a low-energy argon laser to place circumferential burns on the iris, causing the tissue to contract away from the anterior chamber angle. This contraction opens the angle and allows more access for aqueous outflow, which remains the foundational mechanism of the procedure. The classic post-treatment appearance is a ring of small laser burns around the outside of the iris. The technique evolved as a way of reducing intraocular pressure, typically used alongside treatment with eye drops.
The Enduring Impact of Laser Iridoplasty
A recent study published in Clinical & Experimental Ophthalmology sheds light on the enduring effects of laser iridoplasty. Researchers reviewed the electronic health records of 18 sequential patients (23 eyes) with PAC who underwent LI after peripheral iridotomy failed. These patients were followed for four years using Spectralis ASOCT to monitor changes in their eyes.
- Intraocular Pressure (IOP)
- Glaucoma Medications
- Iris Thickness at 350 µm from the scleral spur (IT350)
- Angle Opening Distance at 500 µm (AOD500)
Optimizing Spot Location, Energy, and Safety
Recent research has focused on optimizing laser peripheral iridoplasty technique, with authors noting that so far, little research has been conducted regarding the impact of laser photocoagulation location and energy level on treatment efficacy and safety. The presumed mechanism suggests that the closer the laser spot is to the periphery of the iris, the greater the effect on the drainage angle. In one retrospective, observational case series, argon laser peripheral iridoplasty proved effective in widening residual angle closure following laser peripheral iridotomy, though the study also reported Urrets-Zavalia syndrome as a possible complication and assessed the procedure's safety profile. These findings underscore that both the efficacy and safety parameters of iridoplasty remain active research questions.
A Supportive Tool, Not a Glaucoma Cure
Critics stress that iridoplasty was never developed nor intended to treat glaucoma per se; rather, it is intended to open an appositionally closed angle to avoid acute or chronic angle closure and the development or progression of peripheral anterior synechiae. The procedure is therefore positioned as a supportive tool rather than a primary glaucoma therapy. Even so, presenters at the 10th European Glaucoma Society Congress described laser peripheral iridoplasty as a useful option in eyes with acute angle closure or angle-closure glaucoma where laser peripheral iridotomy has been unsuccessful. The recurring caveat is that the procedure's value depends on the underlying mechanism of closure.
Iridoplasty Alone Versus Combined Treatment
Comparative research has examined laser peripheral iridoplasty both on its own and in combination with laser peripheral iridotomy. One randomized controlled trial protocol describes laser peripheral iridoplasty as an alternative and effective way of widening the angle recess in eyes affected by primary angle closure, and compares laser peripheral iridotomy alone against iridotomy plus iridoplasty applied with a diode laser. Another randomized trial assessed argon laser peripheral iridoplasty as a secondary procedure compared with no further treatment in 22 participants over three months. Taken together, the comparative evidence base remains limited, resting on small trials and ongoing study protocols.
Making Informed Decisions
While this study provides valuable insights into the long-term effects of laser iridoplasty, it’s important to recognize its limitations as a retrospective analysis. Nevertheless, the findings offer a clear illustration of LI's potential to provide lasting opening of the iridocorneal angle. For those seeking alternatives to lens extraction, LI presents itself as an excellent option, especially in lower-risk situations. However, only a qualified ophthalmologist can determine the best course of action based on individual circumstances.
Thermal Retraction of the Iris Periphery
Expert commentary emphasizes that argon laser peripheral iridoplasty works by delivering laser impacts whose thermal effect retracts the periphery of the iris, subsequently widening the iridocorneal angle and facilitating drainage. Research focused on acute primary angle closure has been designed specifically to evaluate the effectiveness and safety of this approach as a treatment for APAC. The mechanism is regarded as well understood at the tissue level, while ongoing studies aim to quantify how reliably the angle-widening effect translates into clinical benefit.
New Indications on the Horizon
Looking ahead, laser iridoplasty is being explored well beyond its traditional role in angle-closure management. At the 1st International Ocular Laser Congress in Barcelona, Dr. Pedro Grimaldos presented a dedicated session on the future of laser iridoplasty, signaling growing interest in refining and expanding the technique. In one notable application, ophthalmologists have described using argon laser iridoplasty to treat visually significant iris obstruction after Boston keratoprosthesis surgery, reporting that the approach shows promise. These developments suggest the procedure may find new indications as techniques evolve.
Weighing Lasers Against Medications
Laser iridoplasty sits within a broader treatment landscape in which immediate management choices for acute primary angle closure must be weighed carefully. Clinical research has directly compared argon laser peripheral iridoplasty against systemic intraocular pressure-lowering medications as the immediate management for acute angle closure, with mid-term results reported. The procedure has also been investigated in related conditions, including phacomorphic glaucoma. Across these contexts, the thermal effect of the laser retracts the peripheral iris to widen the iridocorneal angle and facilitate drainage, making the procedure a point of comparison against pharmacological alternatives.
Reaching Patients Other Treatments Miss
In real-world practice, laser peripheral iridoplasty is applied to patients with specific angle-closure mechanisms, such as plateau iris syndrome, with eyes in one retrospective review confirmed on gonioscopy and ultrasound biomicroscopy before undergoing pattern scanning laser iridoplasty. The procedure is used to eliminate appositional angle closure resulting from mechanisms other than pupillary block, addressing a distinct patient group from those treated with iridotomy alone. For these patients, iridoplasty can relieve appositional closure that would otherwise leave the drainage angle blocked.